59 Integrating deep proteomics profiling with survival analysis to identify novel biomarkers of response to PD-1 blockade in NSCLC patients

• Emanuela Romano,
• Kristina Beeler,
• Kamil Sklodowski,
• Vito Dozio,
• Silvia Lopez-Lastra,
• Andrés Lanzós

Affiliations

Emanuela Romano

2Institut Curie, Paris, France

Kristina Beeler

1Biognosys AG, Schlieren, Switzerland

Kamil Sklodowski

1Biognosys AG, Schlieren, Switzerland

Vito Dozio

1Biognosys AG, Schlieren, Switzerland

Silvia Lopez-Lastra

2Institut Curie, Paris, France

Andrés Lanzós

1Biognosys AG, Schlieren, Switzerland